Welcome to LookChem.com Sign In|Join Free

CAS

  • or

676607-30-0

1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

676607-30-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 676607-30-0 Structure

  • Basic information

    1. Product Name: 1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate
    2. Synonyms: 1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate
    3. CAS NO:676607-30-0
    4. Molecular Formula: C25H30N2O4
    5. Molecular Weight: 422.5167
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 676607-30-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate(676607-30-0)
    11. EPA Substance Registry System: 1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate(676607-30-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 676607-30-0(Hazardous Substances Data)

676607-30-0 Usage

Molecular structure

A spirocyclic compound containing an indoline ring fused to a piperidine ring, with one benzyl and one tert-butyl group attached to the nitrogen atoms.

Potential pharmaceutical applications

The compound may have potential as a drug delivery system or as a prodrug due to the presence of the dicarboxylate moiety, which can be hydrolyzed to release the active pharmaceutical ingredient.

Biological activity

The unique structural features of the spirocyclic ring system may contribute to the compound's biological activity, which warrants further research and development.

Novel drug candidates

Further investigation of 1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate could lead to the discovery of new drug candidates with therapeutic benefits.

Check Digit Verification of cas no

The CAS Registry Mumber 676607-30-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,6,0 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 676607-30:
(8*6)+(7*7)+(6*6)+(5*6)+(4*0)+(3*7)+(2*3)+(1*0)=190
190 % 10 = 0
So 676607-30-0 is a valid CAS Registry Number.

676607-30-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Benzyl 1-tert-butyloxycarbonylspiro[indoline-3,4'-piperidine]-1'-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:676607-30-0 SDS

676607-30-0Relevant articles and documents

NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

-

, (2019/05/16)

Provided are 2-(piperidin-1-yl)pyrimidin-4(3H)-ones or pharmaceutically acceptable salts thereof, each characterized by having a 1,8-diazaspiro[4.5]deca-3-ene, 1-oxa-8-azaspiro[4.5]deca-3-ene, 2,8-diazaspiro[4.5]deca-3-ene, 2-oxa-8-azaspiro[4.5]deca-3-ene, 2,9-diazaspiro[5.5]undeca-3-ene, 1-oxa-9-azaspiro[5.5]undeca-3-ene, 1,9-diazaspiro[5.5]undeca-4-ene, or 3,9-diazaspiro[5.5]undeca-1-ene structure represented by the following general formula (1):

COMPOUNDS AND THERAPEUTIC USES THEREOF

-

, (2013/02/28)

The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and complications associated w

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 676607-30-0